Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT04318366 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

COVID-19 Patients Characterization, Biobank, Treatment Response and Outcome Predictor

Study acronym: COVID-BioB
StatusRecruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated May 8, 2026 (before its estimated June 19, 2026 completion). Its status may not reflect the trial's current state.

Record History

See every version on ClinicalTrials.gov ↗

  1. Primary and study completion dates: Mar 19, 2026 to Jun 19, 2026v13
  2. Re-verified, no change to tracked fieldsv12
  3. Primary and study completion dates: Mar 19, 2025 to Mar 19, 2026v11
  4. Re-verified, no change to tracked fieldsv10
  5. Primary and study completion dates: Mar 19, 2024 to Mar 19, 2025v9
Show 7 earlier versionsHide 7 earlier versions
  1. Re-verified, no change to tracked fieldsv8
  2. Primary and study completion dates: Mar 19, 2023 to Mar 19, 2024v7
  3. Re-verified, no change to tracked fieldsv6
  4. Enrollment target: 1000 to 6000
    • Primary and study completion dates: Mar 19, 2022 to Mar 19, 2023
    v5
  5. Re-verified, no change to tracked fieldsv4
  6. Publications: 14 to 15v3
  7. Study sites: 1 to 13v2
  1. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Collection and analysis of demographic, clinical, radiographic and laboratory characteristics of CoViD-19 patients to identify predictors of disease severity, mortality and treatment response, and to identify subgroup of patients that might benefit from specific therapeutic interventions
Trial Details
NCT Number NCT04318366
Lead Sponsor Università Vita-Salute San Raffaele
Conditions
(from sponsor)		 Coronavirus Infections
Related terms Coronavirus Infections
Enrollment 6,000 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov